| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.54B | 154.92B | 138.25B | 127.82B | 120.64B | 112.62B |
| Gross Profit | 15.06B | 13.74B | 10.48B | 9.23B | 8.39B | 7.73B |
| EBITDA | 29.82B | 29.38B | 33.51B | 26.56B | 25.93B | 21.12B |
| Net Income | 6.86B | 6.66B | 12.25B | 5.92B | 5.65B | 3.02B |
Balance Sheet | ||||||
| Total Assets | 208.46B | 205.37B | 202.61B | 171.89B | 168.51B | 161.95B |
| Cash, Cash Equivalents and Short-Term Investments | 8.03B | 9.16B | 8.37B | 10.15B | 11.04B | 11.98B |
| Total Debt | 109.81B | 108.81B | 107.56B | 96.44B | 97.05B | 96.68B |
| Total Liabilities | 141.90B | 139.97B | 141.60B | 123.51B | 124.83B | 122.24B |
| Stockholders Equity | 65.99B | 64.82B | 60.46B | 48.38B | 43.67B | 39.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.78B | 3.63B | 909.00M | 2.60B | 113.00M |
| Operating Cash Flow | 0.00 | 4.02B | 5.27B | 2.72B | 5.09B | 3.16B |
| Investing Cash Flow | 0.00 | -2.07B | -16.54B | -1.86B | -4.67B | -3.08B |
| Financing Cash Flow | 0.00 | -1.33B | 9.64B | -1.78B | -1.54B | 9.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥122.95B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
76 Outperform | ¥14.47B | 7.11 | ― | 3.03% | 5.72% | 60.38% | |
72 Outperform | ¥1.03T | 10.73 | ― | 3.37% | 5.24% | 69.92% | |
69 Neutral | ¥49.71B | 7.13 | ― | 3.57% | 3.70% | -43.85% | |
64 Neutral | ¥392.93B | 11.14 | ― | 3.62% | -0.03% | -42.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥43.28B | 6.79 | ― | 3.90% | 0.17% | 58.30% |